OncoSil Medical (ASX:OSL) - Managing Director & CEO, Nigel Lange
Managing Director & CEO, Nigel Lange
Source: British Nuclear Medicine Society
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • OncoSil Medical (OSL) has raised about $6 million through its entitlement offer to drive commercialisation and clinical trials across Europe
  • A total of 65.39 million new shares will be issued at a price of 5 cents each
  • The funds will help the company commence clinical trials on its drug to treat pancreatic cancer in the EU
  • In addition, the money will be utilised for working capital and to accelerate commercialisation activities for its OncoSil device in the UK and Europe
  • Shares were trading 6.12 per cent higher today at 5.2 cents each at 3:24 pm AEST

OncoSil Medical (OSL) has raised about $6 million through its entitlement offer to drive commercialisation and clinical trials across Europe.

The company received applications from eligible shareholders for $3.2 million, with the shortfall to be placed with sophisticated and professional investors, raising a further $2.7 million.

A total of 65.39 million new shares will be issued at a price of 5 cents each.

The fresh funds will help the company commence clinical trials on its drug to treat pancreatic cancer in the EU.

In addition, the money will be utilised for working capital and to accelerate commercialisation activities for its OncoSil device in the UK and Europe.

Non-Executive Chairman Otto Buttula subscribed for three million shortfall shares, which will be subject to shareholder approval.

Shares in OncoSil Medical were up 6.12 per cent to 5.2 cents at the close of trading on Thursday.

OSL by the numbers
More From The Market Online

Week 13 Wrap: Easter bunny delivers new all time high for ASX200

Another week, another all time high. The ASX200 clocked 7,901pts on Thursday for the first time…
The Market Online Video

Market Close: Green lights up on ASX for Easter hunt go

The ASX200 closed the day in record territory - nearly a per cent up with every…

Market shrugs as Fisher & Paykel announces mass recall

Fisher & Paykel has initiated a voluntary limited recall of batches of Airvo 1 and my…
The Market Online Video

Market Update: ASX glows red hot with another hit record

The ASX200 is trading up, hitting a new high of 7901 point and eclipsing the last…